Successful management of temporary veno-venous extracorporeal membrane oxygenation for a pediatric lung transplant recipient with bronchiolitis obliterans syndrome awaiting lung re-transplantation: a case report

[1] Date H(2016)Current status and problems of lung transplantation in Japan J Thorac Dis 8 S631-S636

[2] Harnisch LO(2021)Contraindications to the initiation of veno-venous ECMO for severe acute respiratory failure in adults: a systematic review and practical approach based on the current literature Membranes (Basel). 16 246-1060

[3] Moerer O(2021)Lung transplant after long-term veno-venous extracorporeal membrane oxygenation: a case report J Cardiothorac Surg 45 1050-1382

[4] Yoshiyasu N(2021)Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation therapy Artif Organs 189 1374-1713

[5] Sato M(2014)Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score Am J Respir Crit Care Med 39 1704-2114

[6] Anraku M(2013)The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome Intensive Care Med 35 2105-605

[7] Ichiba S(2009)Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database Intensive Care Med 240 595-474

[8] Nakajima J(2004)Extracorporeal life support for severe acute respiratory distress syndrome in adults Ann Surg 66 472-862

[9] Rilinger J(2020)Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure ASAIO J 9 851-1131

[10] Zotzmann V(2021)Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study Lancet Respir Med 8 1121-1722

[1] Date H(2016)Current status and problems of lung transplantation in Japan J Thorac Dis 8 S631-S636

[2] Harnisch LO(2021)Contraindications to the initiation of veno-venous ECMO for severe acute respiratory failure in adults: a systematic review and practical approach based on the current literature Membranes (Basel). 16 246-1060

[3] Moerer O(2021)Lung transplant after long-term veno-venous extracorporeal membrane oxygenation: a case report J Cardiothorac Surg 45 1050-1382

[4] Yoshiyasu N(2021)Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno-venous extracorporeal membrane oxygenation therapy Artif Organs 189 1374-1713

[5] Sato M(2014)Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score Am J Respir Crit Care Med 39 1704-2114

[6] Anraku M(2013)The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome Intensive Care Med 35 2105-605

[7] Ichiba S(2009)Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database Intensive Care Med 240 595-474

[8] Nakajima J(2004)Extracorporeal life support for severe acute respiratory distress syndrome in adults Ann Surg 66 472-862

[9] Rilinger J(2020)Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure ASAIO J 9 851-1131

[10] Zotzmann V(2021)Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study Lancet Respir Med 8 1121-1722